Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 2,763 | 4,068 | 3,456 | 3,924 | 3,829 |
| Gross Profit | 2,763 | 4,068 | 3,456 | 3,924 | 3,829 |
| Operating Expenses | 19,636 | 123,745 | 28,982 | 35,885 | 32,757 |
| Operating Income | -16,873 | -119,677 | -25,526 | -31,961 | -28,928 |
| Other Income | 466 | 780 | 2,603 | 398 | 362 |
| Pre-tax Income | -16,407 | -118,897 | -22,923 | -31,563 | -28,566 |
| Income Tax | N/A | -765 | -19,082 | -5,200 | N/A |
| Net Income Continuous | -16,407 | -118,132 | -3,841 | -26,363 | -28,566 |
| Net Income | $-16,407 | $-118,132 | $-3,841 | $-26,363 | $-28,566 |
| EPS Basic Total Ops | -1.67 | -12.61 | -0.22 | -3.00 | -3.45 |
| EPS Basic Continuous Ops | -1.67 | -12.61 | -0.20 | -3.05 | -3.42 |
| EPS Diluted Total Ops | -1.67 | -12.61 | -0.22 | -3.00 | -3.45 |
| EPS Diluted Continuous Ops | -1.67 | -12.61 | -0.20 | -3.05 | -3.42 |
| EBITDA(a) | $-15,725 | $-27,604 | $-24,399 | $-30,722 | $-27,841 |